These results show that loss-of-function of SRSF10 in the liver is associated with decreased PPARα activity leading to increased susceptibility to NAFLD and obesity-induced metabolic dysfunction. Here, SRSF10 is linked to obesity due to melanocortin 4 receptor deficiency.